These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2142084)

  • 1. Topography of dopamine D-1 and D-2 receptor-mediated rotation after intrastriatal injections of dopamine-related drugs in normosensitive rats.
    Konitsiotis S; Kafetzopoulos E
    Eur J Pharmacol; 1990 Apr; 179(1-2):201-5. PubMed ID: 2142084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
    Dias FR; Carey RJ; Carrera MP
    Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical and behavioural evidence that dopamine D-2 receptors in striatum couple to the Ni regulatory protein and inhibition of cyclic AMP accumulation.
    Kelly E; Willcocks AL; Nahorski SR
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):618-23. PubMed ID: 2819742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dorsal striatal mechanisms involved in the dopamine D2 receptor-mediated potentiation of apomorphine-induced jaw movements.
    Kikuchi de Beltrán K; Koshikawa N; Miwa Y; Kobayashi M
    Eur J Pharmacol; 1994 Jan; 252(1):99-104. PubMed ID: 7908646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity.
    Arnt J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):97-104. PubMed ID: 2864641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopamine D-1 and D-2 receptors in the ventral striatum in the turning behaviour of rats.
    Koshikawa N; Mori E; Maruyama Y; Yatsushige N; Kobayashi M
    Eur J Pharmacol; 1990 Mar; 178(2):233-7. PubMed ID: 1970306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D-1 but not D-2 receptor stimulation of the dorsal striatum potentiates apomorphine-induced jaw movements in rats.
    Koshikawa N; Tomiyama K; Omiya K; de Beltrán KK; Kobayashi M
    Eur J Pharmacol; 1990 Mar; 178(2):189-94. PubMed ID: 1970305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of D1 and D2 antagonists on apomorphine-induced responses of ventral pallidal neurons.
    Maslowski RJ; Napier TC
    Neuroreport; 1991 Aug; 2(8):451-4. PubMed ID: 1832988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats.
    Koshikawa N; Aoki S; Tomiyama K; Maruyama Y; Kobayashi M
    Eur J Pharmacol; 1987 Jan; 133(1):119-25. PubMed ID: 3556388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
    Zhou LW; Zhang SP; Connell TA; Weiss B
    J Pharmacol Exp Ther; 1993 Feb; 264(2):824-30. PubMed ID: 8094754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intrastriatal injections of selective dopamine D-1 and D-2 agonists and antagonists on jaw movements of rats.
    Koshikawa N; Aoki S; Hiruta M; Tomiyama K; Kobayashi M; Tsuboi Y; Iwata K; Sumino R; Stephenson JD
    Eur J Pharmacol; 1989 Apr; 163(2-3):227-36. PubMed ID: 2566502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats.
    Herrera-Marschitz M; Ungerstedt U
    Eur J Pharmacol; 1985 Mar; 109(3):349-54. PubMed ID: 3157586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas.
    Hiroi N; White NM
    Brain Res; 1991 Jun; 552(1):141-52. PubMed ID: 1833032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
    Neisewander JL; O'Dell LE; Redmond JC
    Brain Res; 1995 Feb; 671(2):201-12. PubMed ID: 7743209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different patterns of rotational behavior in rats after dorsal or ventral striatal lesions with ibotenic acid.
    Kafetzopoulos E; Vlaha V; Konitsiotis S
    Pharmacol Biochem Behav; 1988 Feb; 29(2):403-6. PubMed ID: 3362934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I: Comparison between systemic and intrastriatal injections.
    Herrera-Marschitz M; Forster C; Ungerstedt U
    Acta Physiol Scand; 1985 Nov; 125(3):519-27. PubMed ID: 3936338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.